285 related articles for article (PubMed ID: 24852934)
1. Pneumococcal vaccine and patients with pulmonary diseases.
Mirsaeidi M; Ebrahimi G; Allen MB; Aliberti S
Am J Med; 2014 Sep; 127(9):886.e1-8. PubMed ID: 24852934
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
Ludwig E; Mészner Z;
Orv Hetil; 2014 Dec; 155(50):1996-2004. PubMed ID: 25481502
[TBL] [Abstract][Full Text] [Related]
3. [The preventive effect of 23-valent pneumococcal polysaccharide vaccine against drug-resistant Streptococcus pneumonia in patients with chronic respiratory disease].
Kobayashi N; Watanuki Y; Miyazawa N; Kudo M; Inoue S; Sato T; Mishina K; Takahashi H; Kaneko T; Ishigatsubo Y
Nihon Kokyuki Gakkai Zasshi; 2009 Dec; 47(12):1063-9. PubMed ID: 20058680
[TBL] [Abstract][Full Text] [Related]
4. Community-Acquired Pneumococcal Pneumonia in Highly Vaccinated Population: Analysis by Serotypes, Vaccination Status, and Underlying Medical Conditions.
Hyun H; Jang AY; Suh JW; Bae IG; Choi WS; Seo YB; Lee J; Yoon JG; Noh JY; Cheong HJ; Kim WJ; Kim MJ; Song JY
J Korean Med Sci; 2023 Oct; 38(42):e330. PubMed ID: 37904655
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study.
Lawrence H; Pick H; Baskaran V; Daniel P; Rodrigo C; Ashton D; Edwards-Pritchard RC; Sheppard C; Eletu SD; Litt D; Fry NK; Rose S; Trotter C; McKeever TM; Lim WS
PLoS Med; 2020 Oct; 17(10):e1003326. PubMed ID: 33095759
[TBL] [Abstract][Full Text] [Related]
6. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
[TBL] [Abstract][Full Text] [Related]
7. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults.
French N; Gordon SB; Mwalukomo T; White SA; Mwafulirwa G; Longwe H; Mwaiponya M; Zijlstra EE; Molyneux ME; Gilks CF
N Engl J Med; 2010 Mar; 362(9):812-22. PubMed ID: 20200385
[TBL] [Abstract][Full Text] [Related]
8. Role of Pneumococcal Vaccination in Chronic Lung Diseases.
Mahashur AA; Mullerpattan JB
J Assoc Physicians India; 2015 Apr; 63(4 Suppl):31-3. PubMed ID: 26562962
[No Abstract] [Full Text] [Related]
9. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease.
Torres A; Blasi F; Dartois N; Akova M
Thorax; 2015 Oct; 70(10):984-9. PubMed ID: 26219979
[TBL] [Abstract][Full Text] [Related]
10. Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?
Weil-Olivier C; Gaillat J
Vaccine; 2014 Apr; 32(18):2022-6. PubMed ID: 24565755
[TBL] [Abstract][Full Text] [Related]
11. [Effect of influenza and 23-valent pneumococcal polysaccharide vaccinations on elderly with chronic obstructive pulmonary diseases: a community-based intervention study].
Wen Y; He L; Zhai Y; Wu J; Chen YY; Wang H; Zong QQ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):792-798. PubMed ID: 29936749
[No Abstract] [Full Text] [Related]
12. Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010-2015.
Silva-Costa C; Brito MJ; Pinho MD; Friães A; Aguiar SI; Ramirez M; Melo-Cristino J; ;
Emerg Infect Dis; 2018 Jul; 24(7):1307-1314. PubMed ID: 29912700
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age.
Isturiz RE; Hall-Murray C; McLaughlin JM; Snow V; Schmoele-Thoma B; Webber C; Thompson A; Scott DA
Expert Rev Vaccines; 2018 Jan; 17(1):45-55. PubMed ID: 29183235
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine.
Jonsson S; Vidarsson G; Valdimarsson H; Schiffman G; Schneerson R; Jonsdottir I
Eur Respir J; 2002 Oct; 20(4):813-8. PubMed ID: 12412669
[TBL] [Abstract][Full Text] [Related]
15. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases: a matched case-control study.
Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; Gutierrez-Perez A; Vila-Rovira A;
Hum Vaccin Immunother; 2012 May; 8(5):639-44. PubMed ID: 22634442
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal vaccination coverage in France by general practitioners in adults with a high risk of pneumococcal disease.
Kopp A; Mangin O; Gantzer L; Lekens B; Simoneau G; Ravelomanantsoa M; Evans J; Bergmann JF; Sellier P
Hum Vaccin Immunother; 2021 Jan; 17(1):162-169. PubMed ID: 32429734
[No Abstract] [Full Text] [Related]
17. Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations.
Wang Y; Li J; Wang Y; Gu W; Zhu F
Hum Vaccin Immunother; 2018 Apr; 14(4):1003-1012. PubMed ID: 29261406
[TBL] [Abstract][Full Text] [Related]
18. [Pneumococcal vaccine recommendations in chronic respiratory diseases].
Casas Maldonado F; Alfageme Michavila I; Barchilón Cohen VS; Peis Redondo JI; Vargas Ortega DA
Semergen; 2014 Sep; 40(6):313-25. PubMed ID: 25107494
[TBL] [Abstract][Full Text] [Related]
19. [Apexxnar®, 20-valent pneumococcal conjugate vaccine].
Scheen AJ; Louis R; Moutschen M
Rev Med Liege; 2022 Nov; 77(11):678-683. PubMed ID: 36354231
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.
Walters JA; Tang JN; Poole P; Wood-Baker R
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD001390. PubMed ID: 28116747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
